株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血糖モニタリング装置の世界市場の将来予測 (2019~2028年)

Global Glucose Monitoring System Market Forecast 2019-2028

発行 Inkwood Research 商品コード 861605
出版日 ページ情報 英文 210 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.58円で換算しております。
血糖モニタリング装置の世界市場の将来予測 (2019~2028年) Global Glucose Monitoring System Market Forecast 2019-2028
出版日: 2020年05月11日 ページ情報: 英文 210 Pages
概要

2019~2028年に、持続血糖モニタリング装置 (CGMS) 市場は22.31%の、また自己血糖測定装置 (SMBG) 市場では5.22%のCAGRを記録する、と考えられています。市場成長の主な要因として、糖尿病患者の増加や医療費の増大、研究開発 (R&D) 活動の活発化、技術の一体化、経済的なCGMS/SMBGの登場、消費者の健康意識の上昇などが挙げられます。他方、各国政府の厳格な規制体制が市場成長の妨げとなる可能性もあります。

当レポートでは、世界の血糖モニタリング装置 - 持続血糖モニタリング装置 (CGMS) および自己血糖測定装置 (SMBG) - の市場の将来展望について分析し、製品の特性や市場の基本構造、主な促進・抑制要因、市場全体およびコンポーネント別・エンドユーザー別・用途別・年齢層別・地域別の市場動向見通し (今後9年間分)、主要企業のプロファイルなどを調査しております。

第1章 調査範囲・手法

第2章 エグゼクティブサマリー

第3章 市場のダイナミクス

  • 市場の定義
  • 主な市場促進要因
    • 糖尿病の発症率の上昇
    • 医療費の増大
    • 研究開発 (R&D) の強化
    • テクノロジーの統合
    • CGMS・SMBGの利用可能性の向上
    • GMSデバイスの技術進歩
    • 一般市民の認識改善
  • 主な市場抑制要因
    • 政府規制による抑制
    • 継続的血糖モニタリングに対する不十分な医療費償還オプション
    • 診断の機会に対する認識の欠如
    • ベンダー間の競合関係
    • GMSデバイスのデータ読み取りの不正確さ

第4章 主要な分析

  • ポーターのファイブフォース分析
  • 主な購入基準
  • 血糖値の規制
  • バリューチェーン分析
  • 市場機会マトリックス
  • ベンダー情勢
  • 主な投資の考察

第5章 血糖モニタリング装置 (CGMS) の市場:コンポーネントの種類別

  • センサー
  • 送信機・受信機
  • 一体型インシュリンポンプ

第6章 血糖モニタリング装置 (CGMS) の市場:エンドユーザー別

  • ホーム設定
  • 診断と臨床
  • 病院

第7章 血糖モニタリング装置 (CGMS) の市場:年齢層別

  • 成人向け (14歳以上)
  • 児童向け (14歳以下)

第8章 自己血糖測定装置 (SMBG) 市場の概要

第9章 自己血糖測定装置 (SMBG) 市場:コンポーネントの種類別

  • 試験紙
  • 血糖値計
  • ランセット

第10章 自己血糖測定装置 (SMBG) 市場:エンドユーザー別

  • 在宅治療
  • 臨床現場
  • 病院

第11章 自己血糖測定装置 (SMBG) 市場:用途別

  • 1型糖尿病
  • 2型糖尿病
  • 妊娠糖尿病

第12章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • イタリア
    • ベルギー
    • ポーランド
    • その他の欧州諸国
  • アジア太平洋地域
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国
    • インドネシア
    • マレーシア
    • フィリピン
    • タイ
    • ベトナム
    • その他のアジア太平洋諸国
  • 他の国々 (RoW)
    • ラテンアメリカ
    • 中東・アフリカ

第13章 企業プロファイル

  • ABBOTT
  • APEX BIOTECHNOLOGY CORPORATION
  • ARKRAY INC
  • ASCENSIA
  • B BRAUN MELSUNGEN AG
  • BECTON DICKINSON AND COMPANY
  • DEXCOM
  • GLYSENS INC
  • INSULET CORP
  • I-SENS INC
  • JOHNSON AND JOHNSON
  • MEDTRONIC
  • MOREPEN LABORATORIES LTD
  • NEMAURA MEDICAL INC
  • ROCHE DIAGNOSTICS
  • SENSEONICS INC
  • TANDEM DIABETES CARE
  • テルモ
  • WOCKHARDT
  • YPSOMED
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - GLUCOSE MONITORING SYSTEM
  • TABLE 2: DIABETES PREVALENCE IN VARIOUS REGION 2015-2040 (MILLIONS)
  • TABLE 3: GLOBAL CGMS MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 4: GLOBAL CGMS MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL SENSORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 6: GLOBAL SENSORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL TRANSMITTER AND RECEIVERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 8: GLOBAL TRANSMITTER AND RECEIVERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL INTEGRATED INSULIN PUMPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 10: GLOBAL INTEGRATED INSULIN PUMPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL CGMS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: GLOBAL CGMS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL HOME SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 14: GLOBAL HOME SETTINGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL DIAGNOSTICS AND CLINICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: GLOBAL DIAGNOSTICS AND CLINICAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL ADULT POPULATION (>14YEARS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 22: GLOBAL ADULT POPULATION (>14YEARS) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL CHILD POPULATION (≤14YEARS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 24: GLOBAL CHILD POPULATION (≤14YEARS) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 25: IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS
  • TABLE 26: SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS
  • TABLE 27: PRODUCT MATRIX FOR LANCETS
  • TABLE 28: GLOBAL SMBG MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL SMBG MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL TEST STRIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL TEST STRIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL GLUCOSE METER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL GLUCOSE METER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL LANCETS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL LANCETS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL SMBG MARKET, BY END USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL SMBG MARKET, BY END USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL HOME SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL HOME SETTINGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL CLINICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL CLINICAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL SMBG MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL SMBG MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL TYPE 1 DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL TYPE 1 DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL TYPE 2 DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL TYPE 2 DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL GESTATIONAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL GESTATIONAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL CGMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: GLOBAL CGMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL SMBG MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: GLOBAL SMBG MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 56: NORTH AMERICA CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: NORTH AMERICA CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 58: NORTH AMERICA SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: NORTH AMERICA SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 60: EUROPE CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 61: EUROPE CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 62: EUROPE SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 63: EUROPE SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 64: AVERAGE PRICES IN GERMANY FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
  • TABLE 65: GERMANY SMBG SALES CHANNEL 2019-2028 ($ MILLION)
  • TABLE 66: AVERAGE PRICES IN UK FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
  • TABLE 67: THE UNITED KINGDOM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 68: ASIA PACIFIC CGMS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 69: ASIA PACIFIC CGMS, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 70: ASIA PACIFIC SMBG, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 71: ASIA PACIFIC SMBG, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 72: AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
  • TABLE 73: CHINA SMBG SALES CHANNEL 2019-2028 ($ MILLION)
  • TABLE 74: AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 75: INDIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 76: AVERAGE PRICES IN AUSTRALIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 77: AUSTRALIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 78: AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 79: JAPAN SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 80: AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 81: SOUTH KOREA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 82: AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 83: INDONESIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 84: AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 85: MALAYSIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 86: AVERAGE PRICES IN PHILIPPINES FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 87: PHILIPPINES SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 88: AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 89: THAILAND SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 90: AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
  • TABLE 91: VIETNAM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
  • TABLE 92: REST OF WORLD CGMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 93: REST OF WORLD CGMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 94: REST OF WORLD SMBG MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 95: REST OF WORLD SMBG MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: VALUE CHAIN OF CGMS MARKET
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: GLOBAL CGMS MARKET, BY COMPONENT TYPE, IN 2019
  • FIGURE 7: GLOBAL CGMS MARKET, BY SENSORS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL CGMS MARKET, BY TRANSMITTER AND RECEIVERS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL CGMS MARKET, BY INTEGRATED INSULIN PUMPS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL CGMS MARKET, BY END-USER, IN 2019
  • FIGURE 11: GLOBAL CGMS MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL CGMS MARKET, BY DIAGNOSTICS AND CLINICAL, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL CGMS MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, IN 2019
  • FIGURE 15: GLOBAL CGMS MARKET, BY ADULT POPULATION (>14YEARS), 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL CGMS MARKET, BY CHILD POPULATION (≤14YEARS), 2019-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL SMBG MARKET, BY COMPONENT TYPE, IN 2019
  • FIGURE 18: GLOBAL SMBG MARKET, BY TEST STRIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL SMBG MARKET, BY GLUCOSE METER, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL SMBG MARKET, BY LANCETS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL SMBG MARKET, BY END-USER, IN 2019
  • FIGURE 22: GLOBAL SMBG MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL SMBG MARKET, BY CLINICAL, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL SMBG MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL SMBG MARKET, BY APPLICATION, IN 2019
  • FIGURE 26: GLOBAL SMBG MARKET, BY TYPE 1 DIABETES, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL SMBG MARKET, BY TYPE 2 DIABETES, 2019-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL SMBG MARKET, BY GESTATIONAL DIABETES, 2019-2028 (IN $ MILLION)
  • FIGURE 29: NORTH AMERICA CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 30: NORTH AMERICA SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 31: THE UNITED STATES CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 32: THE UNITED STATES SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: CANADA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: CANADA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: EUROPE CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 36: EUROPE SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 37: GERMANY CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: GERMANY SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: THE UNITED KINGDOM CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: THE UNITED KINGDOM SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 41: FRANCE CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: FRANCE SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: RUSSIA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: RUSSIA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: ITALY CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: ITALY SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: BELGIUM CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: BELGIUM SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: POLAND CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: POLAND SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 51: REST OF EUROPE CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: REST OF EUROPE SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 53: ASIA PACIFIC CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 54: ASIA PACIFIC SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 55: CHINA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 56: CHINA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 57: INDIA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 58: INDIA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 59: AUSTRALIA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 60: AUSTRALIA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 61: JAPAN CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 62: JAPAN SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 63: SOUTH KOREA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 64: SOUTH KOREA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 65: INDONESIA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 66: INDONESIA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 67: MALAYSIA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 68: MALAYSIA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 69: PHILIPPINES CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 70: PHILIPPINES SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 71: THAILAND CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 72: THAILAND SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 73: VIETNAM CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 74: VIETNAM SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 75: REST OF APAC CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 76: REST OF APAC SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 77: REST OF WORLD CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 78: REST OF WORLD SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 79: LATIN AMERICA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 80: LATIN AMERICA SMBG MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 81: MIDDLE EAST & AFRICA CGMS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 82: MIDDLE EAST & AFRICA SMBG MARKET, 2019-2028 (IN $ MILLION)
目次
Product Code: 25369

KEY FINDINGS

The global glucose monitoring system CGMS market is anticipated to grow at a CAGR of 22.31%, and the SMBG market is estimated to grow at 5.22% over the forecast period of 2019-2028. The various factors stimulating global market growth are surge in diabetes incidences, rise in healthcare expenditure, growing emphasis on R&D, technology amalgamation, economical CGMS AND SMBG, technological development in GMS devices, and growing awareness among people.

MARKET INSIGHTS

The advent of continuous glucose monitoring systems (CGMS) is a major achievement in glucose monitoring for diabetic patients. Conventionally, CGMS faced competition from finger-based self-monitoring blood glucose (SMBG) devices, as they are affordable, easy-to-use, and easily approved by the authorities. However, CGMS has been well accepted in the US, and increasing its presence in other countries as well. There is an exceptional rise in the diabetic population all over the world, which is driving the market. Eating habits, changing lifestyles, and less physical activities are the major causes of type 2 diabetes in adults. However, type 1 diabetes has also increased.

Government regulations are hindering the growth of the market. The glucose monitoring market is highly regulated by strict rules and approval issues from government authorities, especially the US FDA, which has very stringent regulations. All the companies are focusing on developing innovative and technologically advanced products to stay competitive in the market. The sensors category in the CGMS market by component type segment captured the largest market share in 2019. The sensors dispense signals to show the real-time glucose level of the patients. Lancets are the fastest-growing component type in the SMBG market.

REGIONAL INSIGHTS

The geographical analysis of the global glucose monitoring system market includes market evaluation of North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is the fastest-growing region for both, SMBG and CGMS market. This is mainly due to the growing prevalence of diabetes in the region.

COMPETITIVE INSIGHTS

The introduction of new technologies, coupled with mergers and acquisitions, is resulting in a high competitive rivalry in the market. Some of the eminent players operating in the market are Ypsomed, Abbott Diagnostic, Medtronic, Inc, Terumo, Wockhardt, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARIES

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. RISE IN THE INCIDENCE OF DIABETES
    • 3.2.2. INCREASE IN HEALTHCARE EXPENDITURE
    • 3.2.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
    • 3.2.4. TECHNOLOGY INTEGRATION
    • 3.2.5. INCREASING CGMS AND SMBG AFFORDABILITY
    • 3.2.6. TECHNOLOGICAL ADVANCES IN GMS DEVICES
    • 3.2.7. AWARENESS AMONG THE GENERAL POPULATION
  • 3.3. KEY RESTRAINTS
    • 3.3.1. HINDRANCE FROM GOVERNMENT REGULATIONS
    • 3.3.2. INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
    • 3.3.3. LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
    • 3.3.4. INTENSE COMPETITION AMONG VENDORS
    • 3.3.5. INACCURACY IN READING OF GMS DEVICES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. KEY BUYING CRITERIA
  • 4.3. REGULATION OF BLOOD SUGAR
  • 4.4. VALUE CHAIN ANALYSIS
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE
  • 4.7. KEY INVESTMENT INSIGHTS

5. CGMS MARKET BY COMPONENT TYPE

  • 5.1. SENSORS
  • 5.2. TRANSMITTER AND RECEIVERS
  • 5.3. INTEGRATED INSULIN PUMPS

6. CGMS MARKET BY END-USER

  • 6.1. HOME SETTINGS
  • 6.2. DIAGNOSTICS AND CLINICAL
  • 6.3. HOSPITAL

7. CGMS MARKET BY DEMOGRAPHICS

  • 7.1. ADULT POPULATION (>14YEARS)
  • 7.2. CHILD POPULATION (≤14YEARS)

8. SMBG MARKET OVERVIEW

9. SMBG MARKET BY COMPONENT TYPE

  • 9.1. TEST STRIPS
  • 9.2. GLUCOSE METER
  • 9.3. LANCETS

10. SMBG MARKET BY END USER

  • 10.1. HOME SETTINGS
  • 10.2. CLINICAL
  • 10.3. HOSPITAL

11. SMBG MARKET BY APPLICATION

  • 11.1. TYPE 1 DIABETES
  • 11.2. TYPE 2 DIABETES
  • 11.3. GESTATIONAL DIABETES

12. GEOGRAPHICAL ANALYSIS

  • 12.1. NORTH AMERICA
    • 12.1.1. THE UNITED STATES
      • 12.1.1.1. THE UNITED STATES HEALTH AND HEALTHCARE
      • 12.1.1.2. THE UNITED STATES PHARMACEUTICAL MARKET
    • 12.1.2. CANADA
      • 12.1.2.1. CANADA HEALTH AND HEALTHCARE
      • 12.1.2.2. CANADA PHARMACEUTICAL MARKET
      • 12.1.2.3. CANADA DIABETES MARKET
  • 12.2. EUROPE
    • 12.2.1. GERMANY
      • 12.2.1.1. GERMANY HEALTH AND HEALTHCARE
      • 12.2.1.2. GERMANY PHARMACEUTICAL MARKET
    • 12.2.2. THE UNITED KINGDOM
      • 12.2.2.1. THE UNITED KINGDOM HEALTH AND HEALTHCARE
      • 12.2.2.2. THE UNITED KINGDOM HEALTHCARE PROVISION
      • 12.2.2.3. THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
      • 12.2.2.4. THE UNITED KINGDOM PHARMACEUTICALS
    • 12.2.3. FRANCE
      • 12.2.3.1. FRANCE HEALTH AND HEALTHCARE
      • 12.2.3.2. FRANCE HEALTHCARE PROVISION
    • 12.2.4. RUSSIA
      • 12.2.4.1. RUSSIA HEALTH AND HEALTHCARE
      • 12.2.4.2. RUSSIA PHARMACEUTICAL SERVICES
    • 12.2.5. ITALY
      • 12.2.5.1. ITALY HEALTH AND HEALTHCARE
      • 12.2.5.2. ITALY HEALTHCARE PROVISION
      • 12.2.5.3. ITALY PHARMACEUTICAL MARKET
    • 12.2.6. BELGIUM
    • 12.2.7. POLAND
    • 12.2.8. REST OF EUROPE (ROE)
  • 12.3. ASIA PACIFIC
    • 12.3.1. CHINA
      • 12.3.1.1. CHINA HEALTH AND HEALTHCARE
      • 12.3.1.2. CHINA PHARMACEUTICAL MARKET
      • 12.3.1.3. CHINA DIABETES MARKET
      • 12.3.1.4. MARKET TRENDS
    • 12.3.2. INDIA
      • 12.3.2.1. INDIA HEALTH AND HEALTHCARE
      • 12.3.2.2. INDIA REGULATORY CHANGES
      • 12.3.2.3. INDIA PHARMACEUTICAL MARKET
      • 12.3.2.4. INDIA DIABETES MARKET
    • 12.3.3. AUSTRALIA
      • 12.3.3.1. MARKET TRENDS
    • 12.3.4. JAPAN
      • 12.3.4.1. JAPAN HEALTH AND HEALTHCARE
      • 12.3.4.2. JAPAN PHARMACEUTICAL MARKET
      • 12.3.4.3. JAPAN DIABETES MARKET
      • 12.3.4.4. MARKET TRENDS
    • 12.3.5. SOUTH KOREA
      • 12.3.5.1. MARKET TRENDS
    • 12.3.6. INDONESIA
      • 12.3.6.1. MARKET TRENDS
    • 12.3.7. MALAYSIA
      • 12.3.7.1. MARKET TRENDS
    • 12.3.8. PHILIPPINES
      • 12.3.8.1. MARKET TRENDS
    • 12.3.9. THAILAND
      • 12.3.9.1. MARKET TRENDS
    • 12.3.10. VIETNAM
      • 12.3.10.1. MARKET TRENDS
    • 12.3.11. REST OF APAC
  • 12.4. REST OF WORLD
    • 12.4.1. LATIN AMERICA
      • 12.4.1.1. BRAZIL HEALTH AND HEALTHCARE
      • 12.4.1.2. BRAZIL PHARMACEUTICAL MARKET
      • 12.4.1.3. MEXICO HEALTH AND HEALTHCARE
      • 12.4.1.4. MEXICO PHARMACEUTICAL MARKET
    • 12.4.2. MIDDLE EAST AND AFRICA

13. COMPANY PROFILES

  • 13.1. ABBOTT
  • 13.2. APEX BIOTECHNOLOGY CORPORATION
  • 13.3. ARKRAY INC
  • 13.4. ASCENSIA
  • 13.5. B BRAUN MELSUNGEN AG
  • 13.6. BECTON DICKINSON AND COMPANY
  • 13.7. DEXCOM
  • 13.8. GLYSENS INC
  • 13.9. INSULET CORP
  • 13.10. I-SENS INC
  • 13.11. JOHNSON AND JOHNSON
  • 13.12. MEDTRONIC
  • 13.13. MOREPEN LABORATORIES LTD
  • 13.14. NEMAURA MEDICAL INC
  • 13.15. ROCHE DIAGNOSTICS
  • 13.16. SENSEONICS INC
  • 13.17. TANDEM DIABETES CARE
  • 13.18. TERUMO
  • 13.19. WOCKHARDT
  • 13.20. YPSOMED